COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,758 Articles (22,502 medRxiv, 8,256 bioRxiv)

Most recent first Previous |  Page 1278: Articles 12771-12780  | Next

Association of chronic kidney disease, ethnicity and socioeconomic status with COVID-19 hospitalisation and mortality: a UK Biobank study
Wilkinson, T. J., Lightfoot, C. J., Smith, A. C., Yates, T., Khunti, K., Zaccardi, F.
10.1101/2021.08.02.21261469 — Posted: 2021-08-04
Severity, criticality, and fatality of the SARS-CoV-2 Beta variant
Abu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., YASSINE, H. M., Benslimane, F., Al Khatib, H. A., Tang, P., Hasan, M. R., Coyle, P., AlMukdad, S., Al Kanaani, Z., Al Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G., Al Kuwari, M. G., Butt, A. A., Al Romaihi, H. E., Al-Thani, M. H., Al Khal, A., Bertollini, R.
10.1101/2021.08.02.21261465 — Posted: 2021-08-04
Airway recommendations for perioperative patients during the COVID-19 pandemic: a scoping review
Grudzinski, A., Sun, B., Zhang, M., Crnic, A., Djokhdem, A. H., Hanna, M., Montroy, J., Duggan, L. V., Hamilton, G. M., Fergusson, D. A., Boet, S., McIsaac, D. I., Lalu, M. M.
10.1101/2021.07.30.21261372 — Posted: 2021-08-04
SARS-CoV-2 B.1.351 (beta) variant shows enhanced infectivity in K18-hACE2 transgenic mice and expanded tropism to wildtype mice compared to B.1 variant
Tarres-Freixas, F., Trinite, B., Pons-Grifols, A., Romero-Durana, M., Riveira-Munoz, E., Avila-Nieto, C., Perez, M., Garcia-Vidal, E., Perez-Zsolt, D., Munoz-Basagoiti, J., Raich-Regue, D., Izquierdo-Useros, N., Blanco, I., Noguera-Julian, M., Guallar, V., Lepore, R., Valencia, A., Vergara-Alert, J., Clotet, B., Ballana, E., Carrillo, J., Segales, J., Blanco, J.
10.1101/2021.08.03.454861 — Posted: 2021-08-03
Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern
Mothes, W., Li, W., Chen, Y., Prevost, J., Ullah, I., Lu, M., Gong, S. Y., Tauzin, A., Gasser, R., Vezina, D., Anand, S. P., Goyette, G., Chaterjee, D., Ding, S., Tolbert, W. D., Grunst, M. W., Bo, Y., Zhang, S., Richard, J., Zhou, F., Huang, R. K., Esser, L., Zeher, A., Cote, M., Kumar, P., Sodroski, J., Xia, D., Uchil, P. D., Pazgier, M., Finzi, A.
10.1101/2021.08.02.454546 — Posted: 2021-08-03
Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters
Kulkarni, R., Chen, W.-C., Lee, Y., Kao, C.-F., Hu, S.-L., Ma, H.-H., Jan, J.-T., Liao, C.-C., Liang, J.-J., Ko, H.-Y., Sun, C.-P., Lin, Y.-S., Wang, Y.-C., Wei, S.-C., Lin, Y.-L., Ma, C., Chao, Y.-C., Chou, Y.-C., Chang, W.
10.1101/2021.08.03.454910 — Posted: 2021-08-03
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit.
Hurlburt, N., Homad, L., Siha, I., Jenewein, M. F., MacCamy, A., Wan, Y.-H., Boonyaratanakornkit, J., Sholukh, A. M., Zhou, P., Burton, D., Andrabi, R., Stamatatos, L., Pancera, M., McGuire, A.
10.1101/2021.08.02.454829 — Posted: 2021-08-03
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunization
Lapuente, D., Fuchs, J., Willar, J., Antao, A. V., Everlein, V., Uhlig, N., Issmail, L., Schmidt, A., Oltmanns, F., Peter, A. S., Mueller-Schmucker, S., Irrgang, P., Fraedrich, K., Cara, A., Hoffmann, M., Poehlmann, S., Ensser, A., Pertl, C., Willert, T., Thirion, C., Grunwald, T., Ueberla, K., Tenbusch, M.
10.1101/2021.08.03.454858 — Posted: 2021-08-03
The timing of natural killer cell response in coronavirus infection: a concise model perspective
Xu, X., Sneppen, K.
10.1101/2021.08.02.454730 — Posted: 2021-08-03
Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Yeow, A. E. L., Valtanen, P. G., Al-Delfi, Z., Gummow, J. A., Ferguson, C., O'Connor, S., Reddi, B., Shaw, D., Kok-Lim, C., Gleadle, J. M., Beard, M. R., Barry, S. C., Grubor-Bauk, B., Lynn, D. J.
10.1101/2021.07.30.21261234 — Posted: 2021-08-03 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).